Georgia Keresty Ph.D. serves as Independent Director of the Company.D serves as Independent Director of the Company. serves as Independent Director of the Company. Since 2017, Ms. Keresty has served as the R&D chief operating officer of Takeda, a global research and development driven biopharmaceutical company. From 2003 to 2017 and from 1997 to 1999, she was an executive at Johnson & Johnson. From 1999 to 2003 and from 1983 to 1997, she held roles at Bristol-Myers Squibb Company and Novartis Pharmaceuticals Corporation, respectively. She currently serves as an independent director for Commissioning Agents, Inc., an ESOP global engineering services firm, and has previously served on the board of Janssen Alzheimer Immunotherapy, the board of trustees for Clarkson University, Potsdam, NY and the board of trustees for the NJ Foundation for Aging. Ms. Keresty holds BSc degrees in Chemical Engineering and Computer Science from Clarkson University and Ramapo College of New Jersey; an MS degree in Information Systems from Pace University; an MBA in Operations Management from Rutgers University; a PhD in Operations Management from Rutgers University; and an MPH in Global Health Leadership from the University of Southern California. Ms. Keresty's qualifications to serve on the board of directors include her lengthy experience as a scientific leader driving operational excellence and innovation in the highly regulated pharmaceutical and healthcare industry.
As the Independent Director of Aspen Technology Inc, the total compensation of Georgia Keresty at Aspen Technology Inc is $30,312. There are 13 executives at Aspen Technology Inc getting paid more, with Antonio Pietri having the highest compensation of $7,478,890.
Georgia Keresty is 58, she's been the Independent Director of Aspen Technology Inc since 2019. There are 8 older and 9 younger executives at Aspen Technology Inc. The oldest executive at Aspen Technology Inc is Donald Casey, 73, who is the Independent Director.
Georgia's mailing address filed with the SEC is C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE, MA, 02139.
Over the last 25 years, insiders at Aspen Technology Inc have traded over $77,149,316 worth of Aspen Technology Inc stock. The most active insiders traders include International Corp/Ma Advent, Christopher Pike, and Mark Fusco. On average, Aspen Technology Inc executives and independent directors trade stock every 20 days with the average trade being worth of $4,455,485. The most recent stock trade was executed by Jr. Robert M. Whelan, on 28 August 2024, trading 1,000 units of AZPN stock currently worth $219,100.
Aspen Technology, Inc. develops software for asset performance, monitoring management and optimization solutions.
Aspen Technology Inc executives and other stock owners filed with the SEC include: